Properties (53)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Astra_Pharmaceuticals
gptkb:MedImmune |
gptkbp:awards |
Best Workplaces 2020
Top Employer UK 2021 Global_Health_Partner_of_the_Year_2021 |
gptkbp:CEO |
gptkb:Pascal_Soriot
|
gptkbp:clinicalTrials |
gptkb:COVID-19_vaccine
cancer treatments partnerships with research institutions collaborations with hospitals diabetes treatments global clinical trial networks |
gptkbp:communityEngagement |
health awareness campaigns
employee volunteer programs support for local charities |
gptkbp:employees |
over 14,000
|
gptkbp:founded |
1999
|
gptkbp:headquarters |
gptkb:Cambridge,_England
|
https://www.w3.org/2000/01/rdf-schema#label |
AstraZeneca UK Limited
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:investmentFocus |
expansion of manufacturing facilities
$1 billion in R&D annually collaboration with biotech firms |
gptkbp:market |
$150 billion (2021)
|
gptkbp:parentCompany |
gptkb:AstraZeneca_PLC
|
gptkbp:partnerships |
gptkb:Oxford_University
gptkb:University_of_Cambridge |
gptkbp:patentCitation |
over 30,000 patents filed
|
gptkbp:philanthropy |
community health programs
support for education programs donations to global health initiatives |
gptkbp:products |
vaccines
oncology drugs cardiovascular drugs |
gptkbp:regulatoryCompliance |
WHO prequalification for vaccines
EMA_approvals_for_multiple_drugs FDA_approvals_for_multiple_drugs |
gptkbp:research_areas |
gptkb:Gothenburg_Research_Centre
gptkb:Gaithersburg_Research_Centre gptkb:Cambridge_Research_Centre Moscow_Research_Centre |
gptkbp:researchFocus |
biopharmaceuticals
|
gptkbp:revenue |
$26 billion (2020)
|
gptkbp:subsidiary |
gptkb:AstraZeneca_Japan_K.K.
gptkb:AstraZeneca_India_Pvt._Ltd. gptkb:AstraZeneca_Canada_Inc. gptkb:AstraZeneca_Australia_Pty_Ltd. AstraZeneca_PLC_USA |
gptkbp:sustainabilityInitiatives |
diversity and inclusion programs
water conservation programs carbon neutrality by 2025 |
gptkbp:website |
www.astrazeneca.com
|